Cite
HARVARD Citation
Qiang, S. et al. (2015). Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus. Diabetology & metabolic syndrome. 7 (1), pp. 1-7. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Qiang, S. et al. (2015). Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus. Diabetology & metabolic syndrome. 7 (1), pp. 1-7. [Online].